About the Pharma Insights Journal
The Pharma Insights Journal is a monthly online journal published by PharmaCentral and offers open access for the global community of professionals involved in pharmaceutical R&D and manufacturing. Whether you’re interested in developing new skills, expanding your knowledge or catching up on the latest news, Pharma Insights Journal is the place to find the most relevant information from your peers, manufacturers, journalists and other leading institutions straight. Interested in submitting an article? Email us at editor@pharmacentral.com. We welcome original research, commentaries, infographics, technical guides, press releases and whitepapers. Our article turn-around is 7 days.
Scope
Pharmaceutical Regulation, Process development, Manufacturing, Formulation, Drug Delivery, Excipients, Nutraceuticals, Analytical Science, Supply-chain, Novel Therapeutics and Pharmaceutical Business
Supervising Editor
Dr. Hisham Al-Obaidi University of Reading, UK
Reference numbers
DOI: TBC ©Pharmacentral
Volume 1 Issue 5
Original Research
Development of a Novel Coating for Conventional Non-Functional Applications
Yasuhiro Suzuki and Tatsuya Suzuki Faculty of Pharmaceutical Science, Toho University Introduction Despite the wide availability of alternative formats, solid...
News & Commentary
Challenges facing European Pharmaceutical Manufacturers in 2022
Pharmacentral ReportersIn the run-up to Christmas, there was considerable anxiety about shortages of all sorts of goods, from toys, food,...
January 2022 CHMP Meeting Highlights
The CHMP is the European Medicines Agency’s (EMA) committee responsible for human medicines. It plays a key role in authorisation...
Columnists & Contributors
Are You A Scientist Facing Online Harassment? Here Are 7 Strategies To Help You Cope
Sridhah Naminathan, PhD Clinical Psychologists & Advanced Practitioner, Glasgow, UKSummary If you or someone you know is experiencing online harassment,...
Subscribe to the Pharma Insights Journal for exclusive access to articles hot off the press.
It is 100% free.